Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;126(2):415-422.
doi: 10.1016/j.bja.2020.09.035. Epub 2020 Oct 31.

Polypharmacy and emergency readmission to hospital after critical illness: a population-level cohort study

Affiliations

Polypharmacy and emergency readmission to hospital after critical illness: a population-level cohort study

Angus J Turnbull et al. Br J Anaesth. 2021 Feb.

Abstract

Background: Polypharmacy is common and closely linked to drug interactions. The impact of polypharmacy has not been previously quantified in survivors of critical illness who have reduced resilience to stressors. Our aim was to identify factors associated with preadmission polypharmacy and ascertain whether polypharmacy is an independent risk factor for emergency readmission to hospital after discharge from a critical illness.

Methods: A population-wide cohort study consisting of patients admitted to all Scottish general ICUs between January 1, 2011 and December 31, 2013, whom survived their ICU stay. Patients were stratified by presence of preadmission polypharmacy, defined as being prescribed five or more regular medications. The primary outcome was emergency hospital readmission within 1 yr of discharge from index hospital stay.

Results: Of 23 844 ICU patients, 29.9% were identified with polypharmacy (n=7138). Factors associated with polypharmacy included female sex, increasing age, and social deprivation. Emergency 1-yr hospital readmission was significantly higher in the polypharmacy cohort (51.8% vs 35.8%, P<0.001). After confounder adjustment, patients with polypharmacy had a 22% higher hazard of emergency 1-yr readmission (adjusted hazard ratio 1.22, 95% confidence interval 1.16-1.28, P<0.001). On a linear scale of polypharmacy each additional prescription conferred a 3% increase in hazard of emergency readmission by 1 yr (adjusted hazard ratio 1.03, 95% confidence interval 1.02-1.03, P<0.001).

Conclusions: This national cohort study of ICU survivors demonstrates that preadmission polypharmacy is an independent risk factor for emergency readmission. In an ever-growing era of polypharmacy, this risk factor may represent a substantial burden in the at-risk post-intensive care population.

Keywords: critical illness; drug interactions; emergency readmission; hospital readmission; intensive care; outcome; polypharmacy.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Mean number of monthly prescriptions in the year preceding critical care index admission by age at index admission stratified by (a) gender or (b) social deprivation as determined from Scottish Index of Multiple Deprivation (SIMD, version 2009). First and fifth quintile 95% confidence intervals for social deprivation are only shown for clarity. CI, confidence interval.
Fig 2
Fig 2
Cumulative incidence plot for 1-yr emergency readmission by time since discharge from hospital after index critical care stay stratified by presence of polypharmacy.
Fig 3
Fig 3
Predicted probability of 1-yr emergency readmission after discharge from hospital containing index critical care stay according to age, stratified by presence of polypharmacy. CI, confidence interval.
Fig 4
Fig 4
Predicted probability of 1-yr emergency readmission after discharge from hospital containing index critical care stay on a linear scale of polypharmacy. Shaded area represents 95% confidence interval.

Similar articles

Cited by

References

    1. Guthrie B., Makubate B., Hernandez-Santiago V. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015;13:74. - PMC - PubMed
    1. Avery A.J., Ghaleb M., Barber N. The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Br J Gen Pract. 2013;63:e543–e553. - PMC - PubMed
    1. Doan J., Zakrzewski-Jakubiak H., Roy J. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013;47:324–332. - PubMed
    1. Pirmohamed M., James S., Meakin S. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–19. - PMC - PubMed
    1. Uijtendaal E.V., van Harssel L.L.M., Hugenholtz G.W.K. Analysis of potential drug-drug interactions in medical intensive care unit patients. Pharmacotherapy. 2014;34:213–219. - PubMed

Publication types

MeSH terms

LinkOut - more resources